Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Current Deferred Revenue (2022 - 2025)

Stemtech's Current Deferred Revenue history spans 4 years, with the latest figure at $88393.0 for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue changed N/A to $88393.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $88393.0, a N/A change, with the full-year FY2024 number at $1463.0, down 97.39% from a year prior.
  • Current Deferred Revenue hit $88393.0 in Q3 2025 for Stemtech, down from $98249.0 in the prior quarter.
  • Over the last five years, Current Deferred Revenue for STEK hit a ceiling of $98249.0 in Q2 2025 and a floor of $1463.0 in Q4 2024.
  • Historically, Current Deferred Revenue has averaged $61533.5 across 4 years, with a median of $75907.0 in 2023.
  • The widest YoY moves for Current Deferred Revenue: up 75.49% in 2024, down 97.39% in 2024.
  • Tracing STEK's Current Deferred Revenue over 4 years: stood at $39170.0 in 2022, then soared by 43.07% to $56039.0 in 2023, then tumbled by 97.39% to $1463.0 in 2024, then soared by 5941.9% to $88393.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for STEK at $88393.0 in Q3 2025, $98249.0 in Q2 2025, and $6778.0 in Q1 2025.